英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
SP2509
|
1423715-09-6 |
SP259
|
CS-1755;SP 2509;SP-2509;3-(4-吗啉基磺酰基)苯甲酸 (2E)-2-[1-(5-氯-2-羟基苯基)亚乙基]酰肼;SP-2509;HCI-2509
|
C19H20ClN3O5S |
437.91 | |
SAR191801
|
1234708-04-3 |
SAR19181
|
CS-1754;N-[[3-[5-(1-羟基-1-甲基乙基)-1,2,4-恶二唑-3-基]苯基]甲基]-2-(2-吡啶基)-5-嘧啶甲酰胺
|
C22H20N6O3 |
416.4326 | |
BAF312 (Siponimod(
|
1230487-00-9 |
辛波莫德
|
CS-1753;SIPONIMOD;SIPONIMOD [INN];BAF-312;BAF 312;辛波莫德;S1P受体激动剂
|
C29H35F3N2O3 |
516.59501 | |
Remodelin
|
1622921-15-6 |
REMODELIN
|
CS-1751;4-[2-(2-环戊基亚基肼基)-4-噻唑基]苯甲腈氢溴酸盐
|
C15H15BrN4S |
363.2754 | |
Ro 48-8071 fumarate
|
189197-69-1 |
RO 48-871富马酸酯
|
Aids163155;Aids-163155;OSC Inhibitor, Ro 48-8071 - CAS 189197-69-1 - Calbiochem;Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]-, (2E)-2-butenedioate (1:1);(4-((6-(allyl(methyl)amino)hexyl)oxy)-2-fluorophenyl)(4-bromophenyl)methanone fumarate Ro48-8071;Methanone, (4-bromophenyl)[2-fluoro-4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]-,(2E)-2-butenedioate;(4-Bromophenyl)[2-fluoro-4-[[6-(methyl-2-propen-1-ylamino)hexyl]oxy]phenyl]methanone;Ro 48-8071 fumarate salt
|
C23H27BrFNO2.C4H4O4 |
564.45 | |
JNJ-31020028
|
1094873-14-9 |
JNJ 31228
|
|
C34H36FN5O2 |
565.680343 | |
Salirasib
|
162520-00-5 |
Salirasib
|
2-[[(2E,6E)-3,7,11-三甲基-2,6,10-十二烷三烯-1-基]硫代]苯甲酸;反,反法尼基硫代水杨酸(SALIRASIB);2-(((2E,11-三甲基十二碳-2,10-三烯-2-基)硫基)苯甲酸;反,反法尼基硫代水杨酸;沙利雷塞;法尼基硫代水杨酸
|
C22H30O2S |
358.54 | |
ML141
|
71203-35-5 |
ML 141
|
5-(4-甲氧基苯基)-1-(4-氨基磺酰基苯基)-3-苯基-2-吡唑啉;CS-1743;ML141;ML 141;ML141;ML 141;CID-2950007;ML 141;5-(4-甲氧基苯基)-1-(4-氨基磺酰基苯基)-3-苯基-2-吡唑啉
|
C22H21N3O3S |
407.48544 | |
GS967
|
1262618-39-2 |
GS967
|
GS-967;GS 967;GS-458967;GS 458967;GS458967;CS-1742;GS967>98%;6-[4-(三氟甲氧基(苯基]-3-(三氟甲基([1,2,4]三唑并[4,3-A]吡啶
|
C14H7F6N3O |
347.215299 | |
WEHI-539
|
1431866-33-9 |
WEHI539
|
WEHI-539;(E)-5-(3-(4-(aminomethyl)phenoxy)propyl)-2-(8-(2-(benzo[d]thiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)thiazole-4-carboxylic acid;WEHI-539 ( CT-WE539);5-[3-[4-(Aminomethyl)phenoxy]propyl]-2-[8-[2-(2-benzothiazolyl)hydrazinylidene]-5,6,7,8-tetrahydro-2-naphthalenyl]-4-thiazolecarboxylic acid;(E)-5-(3-(4-(Aminomethyl)phenoxy)propyl)-2-(8-(2-(benzo[d]thiazol-2-yl)hydrazono)-5,6,7,8-tetr
|
|||
GSK1324726A
|
1300031-52-0 |
GSK1324726A (I-BET726)
|
CS-1736;4-[(2S,4R)-1-乙酰基-4-[(4-氯苯基)氨基]-2-甲基-1,2,3,4-四氢-6-喹啉基]苯甲酸;I-BET726;I-BET 726;GSK1324726A (I-BET726)
|
C25H23ClN2O3 |
434.91472 | |
BLZ945
|
953769-46-5 |
BLZ945
|
CS-1735;BLZ-945;BLZ 945
|
C20H22N4O3S |
398.47868 | |
SCR7
|
1533426-72-0 |
SCR7
|
CS-1733;2,3-二氢-5,6-二[(E)-(苯基亚甲基)氨基]-2-硫代-4(1H)-嘧啶酮
|
C18H14N4OS |
334.4 | |
ANA-12
|
219766-25-3 |
ANA-12
|
N-[2-[[(六氢-2-氧代-1H-氮杂卓-3-基)氨基]羰基]苯基]苯并[B]噻吩-2-甲酰胺
|
C22H21N3O3S |
407.48544 | 803-090-7 |
ITD-1
|
1099644-42-4 |
ITD 1
|
ETHYL 4-{[1,1'-BIPHENYL]-4-YL}-2,7,7-TRIMETHYL-5-OXO-1,4,6,8-TETRAHYDROQUINOLINE-3-CARBOXYLATE;ITD-1;4-[1,1'-Biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-3-quinolinecarboxylic acid ethyl ester;AOB6123;SCHEMBL3239096
|
|||
GSK2110183
|
1047634-63-8 |
AFURESERTIB (GSK211183)
|
CS-1729;GSK2110183;GSK 2110183;GSK-2110183;AFURESERTIB (GSK2110183)
|
C18H16Cl2F2N4OS |
445.313646 | |
Molidustat(BAY-85-3934)
|
1154028-82-6 |
MOLIDUSTAT
|
1,2-二氢-2-[6-(4-吗啉基)-4-嘧啶基]-4-(1H-1,2,3-三唑-1-基)-3H-吡唑-3-一;CS-1728;MOLIDUSTAT;消毒剂(BAY-85-934);BAY 85-3934;BAY-85-3934
|
C13H14N8O2 |
314.30266 | 815-038-0 |
NVP 231
|
362003-83-6 |
NVP-231
|
|
C25H25N3O2S |
431.5499 | |
AG-120-Ivosidenib
|
1448347-49-6 |
RG12
|
CS-1721;AG120;AG 120;RG120;艾伏尼布;RG120 100MG;AG120消旋体
|
C28H22ClF3N6O3 |
582.96089 | |
X-396
|
1365267-27-1 |
恩沙替尼(X 396)
|
CS-1720;恩沙替尼;恩沙替尼(X 396);恩沙替尼(X-376)
|
C25H25Cl2FN6O3 |
547.408803 |